1 terminated. 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 1 | Terminated 1 |
Follow Castleman Disease: new trials by email Literature Review of Castleman Disease trials Research Report on Castleman Disease
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Rituximab in the Treatment of HIV Associated Multicentric Castleman Disease Dependent on Chemotherapy Rituximab - HIV Infections, Giant Lymph Node Hyperplasia | Phase 2 | Terminated | French National Agency for Research on AIDS and Viral Hepatitis | 25 | 2003-05-01 | 2007-01-12 |
HIV Infections (1) · Sarcoma, Kaposi (1)
Blood-Borne Infections (1) · Communicable Diseases (1) · DNA Virus Infections (1) · Genital Diseases (1) · Hemic and Lymphatic Diseases (1) · Herpesviridae Infections (1) · Immune System Diseases (1) · Immunologic Deficiency Syndromes (1) · Immunoproliferative Disorders (1) · Infections (1) · Lentivirus Infections (1) · Lymphatic Diseases (1) · Lymphoproliferative Disorders (1) · Neoplasms (1) · Neoplasms by Histologic Type (1)
Rituximab (1)
French National Agency for Research on AIDS and Viral Hepatitis (1)